Skip to main content
. 2020 Mar 3;38(12):1284–1292. doi: 10.1200/JCO.19.00510

FIG 2.

FIG 2.

Spectrum of magnetic resonance (MR)–based response patterns of hormone receptor–positive ductal carcinoma in situ to preoperative letrozole therapy. Patients exhibited variable patterns at baseline and at 3- and 6-month MR imaging timepoints. The predominant radiographic patterns were (A) no response (17.9% at 6 months), (B) partial response (49.2% at 6 months), or (C) complete response to therapy (32.8% at 6 months).